Sbi Securities Co., Ltd. Summit Therapeutics Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,221 shares of SMMT stock, worth $23,528. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,221Holding current value
$23,528% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
213Shares Held
78.1MCall Options Held
2.16MPut Options Held
3.1M-
Baker Bros. Advisors LP New York, NY24.4MShares$471 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$225 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$152 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$105 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$66.8 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.88B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...